title: Very late bioresorbable vascular scaffold thrombosis following discontinuation of antiplatelet therapy.
authors.affiliation: Department of Cardiology, University Medical Centre Utrecht, Room E04.201, Heidelberglaan 100, Utrecht 3584 CX, The Netherlands.
authors.forename: Leo
authors.initials: L
authors.lastname: Timmers
authors.affiliation: Department of Cardiology, University Medical Centre Utrecht, Room E04.201, Heidelberglaan 100, Utrecht 3584 CX, The Netherlands.
authors.forename: Pieter R
authors.initials: PR
authors.lastname: Stella
authors.affiliation: Department of Cardiology, University Medical Centre Utrecht, Room E04.201, Heidelberglaan 100, Utrecht 3584 CX, The Netherlands p.agostoni@umcutrecht.nl.
authors.forename: Pierfrancesco
authors.initials: P
authors.lastname: Agostoni
mesh_terms: D020341:Absorbable Implants; D000241:Adenosine / Q000031:analogs & derivatives / Q000627:therapeutic use; D000328:Adult; D001241:Aspirin / Q000627:therapeutic use; D001807:Blood Vessel Prosthesis; D000077144:Clopidogrel; D006083:Graft Occlusion, Vascular / Q000188:drug therapy / Q000209:etiology*; D006801:Humans; D008297:Male; D009203:Myocardial Infarction / Q000188:drug therapy / Q000209:etiology*; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D058921:Purinergic P2Y Receptor Antagonists / Q000627:therapeutic use; D015607:Stents; D000077486:Ticagrelor; D013988:Ticlopidine / Q000031:analogs & derivatives / Q000627:therapeutic use; D000077466:Tirofiban; D054457:Tissue Scaffolds; D014443:Tyrosine / Q000031:analogs & derivatives / Q000627:therapeutic use
chemical_list: D010975:Platelet Aggregation Inhibitors; D058921:Purinergic P2Y Receptor Antagonists; D014443:Tyrosine; D000077144:Clopidogrel; D000077466:Tirofiban; D000077486:Ticagrelor; D000241:Adenosine; D013988:Ticlopidine; D001241:Aspirin